In the 20th-century statistics wars, Bayesians were underdogs. Now their methods may help speed treatments to market.

In today’s ACT Brief, we explore how Bayesian trial designs are gaining traction in rare disease research, what priorities clinical operations leaders should focus on in 2026, and how rare disease ...

As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

This webinar introduced healthcare researchers to Bayesian meta-analysis methods, challenging the perception that these methods are inaccessible to non-statistical researchers. The session ...

Objectives High-dose rifamycin (HDR) regimens have demonstrated significant potential in tuberculosis (TB) treatment. This study aims to evaluate the efficacy and safety profile of different HDR ...

This study proposes an important new approach to analyzing cell-count data, which are often undersampled and cannot be accurately assessed using traditional statistical methods. The case studies ...

1 Department of Computer Science, Rochester Institute of Technology, Rochester, USA. 2 Department of Computer Science, Rutgers University, New Brunswick, USA. Language identification is a fundamental ...

Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. In this paper, we introduce a methodology to improve upon the ...

Abstract: This work introduces the three-parameter sine Kumaraswamy Shanker distribution (SKSD), a novel extension of the Shanker distribution that seeks to further enhance the flexibility of ...